Company: HCTI
Filing Date: 2025-11-19
Form Type: 424B5
Source: 0001213900-25-112544
Chunk: 45

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-19
Form: 424B5
Chunk 45
---
 Incorporation also provides that
this choice of forum provision does not apply to claims arising under federal securities laws.

Section 203 of the Delaware General Corporation Law

We are subject to the provisions of Section 203
of the DGCL regulating corporate takeovers. This statute prevents certain Delaware corporations, under certain circumstances, from engaging
in a “business combination” with:

| ● | a                                                                                                                  
 stockholder who owns 15% or more of our outstanding voting stock (otherwise known as an “interested stockholder”); |

| ● | an                                         
 affiliate of an interested stockholder; or |

| ● | an                                                                                                                                
 associate of an interested stockholder, for three years following the date that the stockholder became an interested stockholder. |

A “business combination” includes
a merger or sale of more than 10% of our assets. However, the above provisions of Section 203 do not apply if:

| ● | our                                                                                                                         
 board of directors approves the transaction that made the stockholder an “interested stockholder,” prior to the date of the 
 transaction; or                                                                                                             |

| ● | after                                                                                                                                  
 the completion of the transaction that resulted in the stockholder becoming an interested stockholder, that stockholder owned at least 
 85% of our voting stock outstanding at the time the transaction commenced, other than statutorily excluded shares of common stock.     |

<div align='center'>14

DESCRIPTION OF PREFERRED STOCK</div>

This section describes the general terms and provisions
of the preferred stock that we may offer by this prospectus. The prospectus supplement will describe the specific terms of the series
of preferred stock offered through that prospectus supplement. Those terms may differ from the terms discussed below. Any series of preferred
stock that we issue will be governed by our certificate of incorporation, as amended, including the certificate of designations relating
to such series of preferred stock, and our by-laws.

As of January 4, 2024, we have designated 20,000
shares of preferred stock as Series A Super Voting Preferred Stock, of which 6,000 shares are issued and outstanding.

We will fix the rights, preferences, privileges,
and restrictions of the preferred stock of each series in the certificate of designations relating to that series. We will incorporate
by reference as an exhibit to the registration statement that includes this prospectus the form of any certificate of designations that
describes the terms of the series of preferred stock we are offering before the issuance of the